SL Investment

SL investment (SLi) aims at a company with global standards through management by principle and transparency. SLi is a venture capital firm founded in February 2000 and has widely invested in the companies from early to mezzanine stage, in the field of semiconductors, display (AMOLED, LED, LCD), renewable energy, and health care industry. Since its incorporation, SLi has recorded black-ink balances for 12 consecutive years with zero debt and also has successfully dissolved all the five funds with outstanding earning rates. SLi tries to raise the value of venture companies not only by offering funds but by supporting the management omnidirectionally after its investment. Consequently, 31 companies have been successfully listed in KOSDAQ market for 12 years and all the companies have positioned as leading firms in their specific fields.

Minju Ahn

Managing Director

Jae-Sung Han

Managing Director

Seunghun Lee

CEO

Minju Ahn Ph.D

Executive Director and Investment Professional

34 past transactions

Youniv

Venture Round in 2023
Youniv is a video content platform for university students in Korea.

Zenerate

Seed Round in 2022
Zenerate provides AI-powered feasibility solutions for real estate development.

D'CENT

Series A in 2021
D'CENT provides cryptocurrency hardware wallet for keeping crypto assets secure.

Greenergy

Series A in 2021
Greenergy designs and manufactures lithium-ion rechargeable batteries through Greenergy's technology.

URBANPLAY

Series A in 2021
UrbanPlay designs cultural city of emotion by solving urban issues through accessible technology.

N.THING

Series B in 2021
Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by combining IoT technology and data. It developed the world’s first modular vertical farm ‘CUBE’ which is easy to expand. N.THING CUBE is a modularized farm with mass productivity where a dedicated OS provides the most optimized environment for each crop so as to create maximized efficiency. N.THING is the world’s first smart farming company that won the iF Design Award, Architecture in 2020. Also, it is a winner of Best of Innovation at the CES 2020 for its excellence in technology, which is the first ever in the agricultural field. N.THING is planning to expand its business on a large scale this year after it successfully completes the PoC process in the U.A.E. Our North American branch office located in New York. N.THING hopes to connect people to nature, things to things, people to things, and people to people through IoT technologies by creating Number of Things out of Nothing. . CUBE : CUBE is internet connected modular container vertical farm. It's an ultimate indoor farm which contains LED technology, real time monitoring system through IoT sensors, collected cultivation data, and upgradable software. We deliver the farm of the desired container form to the desired place. SQUARE : SQUARE is modular hydroponic kit. SQUARE can connect each module and share water. Users can connect as many as they want, grow greens and herbs, and make food great themselves. Each Square consists of four Pickcells, which contains special nutrient-rich sponge. With special sponge and hydroponic, it gives the most simple and effective gardening experience. Planty : Planty is the first Internet-connected social pot in the world. Planty gives pleasure to grow plants with your family, friend, and colleague. Planty enables the user to monitor the environmental information on temperature, soil moisture, and ambient light around plants and give water to plants any me or anywhere. Life : Life is a smart gardening journal aimed at the gardening sector. Plant lovers and gardeners are able to record their gardening activities and information and share them through Social Media. The user can easily insert weather data, location data, gardening activities, and plants’ events. Moreover, all the gardening data can be shared through social media. Sikmulsung: Sikmulsung is our show room to explore 'freshness' of our product and service. It is a place for everyone seeking for 'freshness' in visual, in texture, in taste, in flavor or even in atmosphere with, N.THING's in-store farm, exclusively made for Sikmulsung, special F&B's and our end products.

NEURIVE

Seed Round in 2021
NEURIVE is a medical research and development company for electronic and digital medicines.

Seawith

Series A in 2021
Seawith is a biotechnology startup developing cell-cultured steak from seaweed. Yo.od, a low-iodine seaweed developed by Seawith, is aimed at consumers with low iodine resistance and high iodine sensitivity. Seawith creates its own culture media from microalgae, which provides the benefits of algae nutrition while also being much cheaper due to the abundance of microalgae.

SIR.LOIN

Series B in 2021
SIR.LOIN is an e-commerce store for Korean beef.

WHYNOT Media

Series C in 2021
WHYNOT Media provides content IP production, short form drama, web entertainment, branded content, transmedia storytelling, short-form drama, content IP production, branded content, k-drama, and transmedia storytelling services.

Cenyx Biotech

Series A in 2021
Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.

NEXEL

Series B in 2021
Operator of a biotechnology company intended to provide drug discovery pipelines to treat diseases. The company develops high-quality iPSC-derived cell products through embryonic stem cell technology, enabling clients to conquer unmet medical needs and iPSC technology

Biobab AiBIO

Series A in 2021
Biobab AiBIO is a biotechnology company that develops drugs utilize artificial intelligence.

everyone's kitchen

Series A in 2021
everyone's kitchen helps in lowering the high cost burden for starting a business.

ImmunoMet Therapeutics

Venture Round in 2021
ImmunoMet Therapeutics is a development-stage biopharmaceutical company focused on the development and commercialization of novel oncology products that are aimed to improve the quality of life of cancer patients. With more than 6 years of experience in the field of cancer metabolism and immunometabolism, ImmunoMet has developed a comprehensive pipeline of metabolic regulators preferentially targeting the cellular metabolism of drug-resistant cancer subpopulations and immuno-suppressors of anti-cancer effector T cells.

B:eat Corp

Series A in 2021
B: eat is a retail automation platform intended to run a robot-based cafe.

Agreable

Series B in 2020
Agreable is a brand commerce startup that manufactures and distributes lifestyle products.

Lab n People

Series B in 2020
Lab & People is a HealthTech company that is improving the drug delivery system. We have developed a microneedle patch using bioabsorbable metals. Our microneedle patch uses thin, soft needles that penetrate directly into the skin layer containing gout cells, thus minimizing pain. It also increases transmission efficiency by using metals such as magnesium, zinc, and calcium, which are highly absorbable by the body. We have four products: 1. Flexible bioabsorbable metal Our flexible bioabsorbable metal technology secures biocompatibility according to ISO 10993. 19 kinds of materials were developed to provide mechanical properties. Decomposition characteristics can be controlled. Our wire rods are of similar technology to that produced by industry leader Fort Wayne Metals in the United States, and we are the only company producing this kind of metal plate worldwide. Innovative materials and products can be supplied to the implant and drug delivery market at an unrivaled level. 2. Bioabsorbable metal implant Micro-invasive aesthetic medical devices can lift faces, breasts, thighs, etc. within 15 minutes. We are expected to start clinical trials with this technology in 2021, with approval by 2022. After initial approval, material-related safety data can be used in the same way, thus securing a product portfolio and accelerating the approval period and commerical competitiveness over time. 3. Bioabsorbable metal microneedle We are the first in the world to commercialize microneedles with flexible bioabsorbable metal using only essential elements in the human body. In Korea, sales are expanding through our own distribution network (on/offline in Olive Young in 2020), and exports are expanding to Japan, Singapore, Hong Kong, and Russia. Our Microneedle Patch is a platform technology that enables the development of derivative products for each disease. NDAs (Confidentiality agreement) with global companies and pharmaceutical companies have been signed and discussions for cooperation are being initiated. 4. Minimal invasive medical device Minimally-invasive medical devices for treatment of spinal stenosis can remove lesions that cause spinal stenosis within 30 minutes without surgery. This technology is currently in the approval stage with the KFDA and is preparing for mass production. We are expected to generate sales from 2021.

SN BioScience

Series B in 2020
SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA), peptide and protein to deliver in the form of nano-micelle, nanoparticle or liposome. Their proprietary “double core-shell technology” and pool of acceptable lipids and polymers could help your research that having difficulties in solubility or delivery.

URBANPLAY

Series A in 2019
UrbanPlay designs cultural city of emotion by solving urban issues through accessible technology.

WHYNOT Media

Series B in 2019
WHYNOT Media provides content IP production, short form drama, web entertainment, branded content, transmedia storytelling, short-form drama, content IP production, branded content, k-drama, and transmedia storytelling services.

Lab n People

Seed Round in 2019
Lab & People is a HealthTech company that is improving the drug delivery system. We have developed a microneedle patch using bioabsorbable metals. Our microneedle patch uses thin, soft needles that penetrate directly into the skin layer containing gout cells, thus minimizing pain. It also increases transmission efficiency by using metals such as magnesium, zinc, and calcium, which are highly absorbable by the body. We have four products: 1. Flexible bioabsorbable metal Our flexible bioabsorbable metal technology secures biocompatibility according to ISO 10993. 19 kinds of materials were developed to provide mechanical properties. Decomposition characteristics can be controlled. Our wire rods are of similar technology to that produced by industry leader Fort Wayne Metals in the United States, and we are the only company producing this kind of metal plate worldwide. Innovative materials and products can be supplied to the implant and drug delivery market at an unrivaled level. 2. Bioabsorbable metal implant Micro-invasive aesthetic medical devices can lift faces, breasts, thighs, etc. within 15 minutes. We are expected to start clinical trials with this technology in 2021, with approval by 2022. After initial approval, material-related safety data can be used in the same way, thus securing a product portfolio and accelerating the approval period and commerical competitiveness over time. 3. Bioabsorbable metal microneedle We are the first in the world to commercialize microneedles with flexible bioabsorbable metal using only essential elements in the human body. In Korea, sales are expanding through our own distribution network (on/offline in Olive Young in 2020), and exports are expanding to Japan, Singapore, Hong Kong, and Russia. Our Microneedle Patch is a platform technology that enables the development of derivative products for each disease. NDAs (Confidentiality agreement) with global companies and pharmaceutical companies have been signed and discussions for cooperation are being initiated. 4. Minimal invasive medical device Minimally-invasive medical devices for treatment of spinal stenosis can remove lesions that cause spinal stenosis within 30 minutes without surgery. This technology is currently in the approval stage with the KFDA and is preparing for mass production. We are expected to generate sales from 2021.

Mitoimmune Therapeutics

Series A in 2019
Mito Immune Therapeutics is a drug research and development biotech company.

SOS LAB

Series A in 2018
SOS Lab, a LiDAR development company focusing on core technology for self-driving cars, plans to present its differentiated hybrid LiDAR system, the SL-1 SOS LAB's long-range, hybrid scanning design combines the advantages of the widely-used motor scanning system with a solid-state MEMS mirror, and will be offered at a much lower price point compared to traditional LiDAR products on the market today. SL-1 is expected to play an important role in the popularization and accessibility of self-driving cars. In addition to the SL-1, SOS LAB offers two additional LiDAR products designed to integrate safe, effective, and affordable LiDAR technology into various industries: the GL-3 for factory automation and robotics, and the TL-3 for security and automatic doors. SOS LAB is also focusing on combining hardware-based sensors and AI-based object recognition and tracking technology using 3D point cloud LiDAR data, and plans to provide LiDAR data space/object recognition solutions for self-driving vehicles. SOS LAB includes jointly developing their hybrid LiDAR with a partner automotive electronic equipment field company, continuing to develop the next generation of Solid-State-LiDAR with global semiconductor companies to overstep the limits of OPA-method LiDAR, and extending the global footprint of SOS LAB to provide the smartest solutions for self-driving and ADAS markets. SOS LAB is planning to enter global markets based on its R&D centers in Seoul and Gwangju and business centers in Silicon Valley.

Fresh Easy

Series A in 2018
Fresh Easy is a distributor of meal kits.

JLK

Venture Round in 2018
JLK is an Artificial Intelligence based medical and security solutions company. They developes artificial intelligence ,medical solutions and data analysis. They provide services in artificial intelligence medical analysis platform, remote artificial intelligence healthcare platform, and artificial intelligence total data management platform company.

Caret Games

Venture Round in 2018
Caret Games is a company specialized in developing mobile games with over 50 employees based on South Korea. The company consists of talented developers and they are developing games with passion. Caret Games developed Full3D mobile MMORPG ‘RebirthM’ in the end of 2017. The company is trying to make a game which many people can enjoy and play for a long time, and the first is ‘RebirthM’. Caret Games services 'RebirthM'​ directly in South Korea and is currently preparing for global service. About "Rebirth M"​! The game also known as Rebirth: Shadow of Salvation, is a mobile MMORPG that’s supposed to rival PC MMORPGs. Made with Unity3D, the game boasts high graphics and PC-like gameplay experience. Now that it’s been more than a year since its announcement in South Korea, the game is finally out in Brazil which a global release will follow suit later.

Urbanbase

Series A in 2017
We provide a platform of VR and AR tools for architecture and interior design. Urbanbase has patented technology of creating 2D floorplans in 3D, AR and VR, in just a few seconds. Urbanbase offers B2C VR home furnishing platform and AR mobile application for revolutionary interior design experience, as well as B2B sales tool based on internally developed 3D, AR, VR APIs for various types of businesses such as real estate, home designing, retail and many more. Current clients include LG, iLoom, Daelim and over 40 interior / furniture companies.

Wantedlab

Series B in 2017
There are currently over 5,000 companies and hundreds of thousands of users on the Wanted platform. Since 2015, companies such as IBM, Facebook, Microsoft, Ebay, Wework, Rakuten and Tencent have been using Wanted to recruit the best talent in Asia. Founded in Korea, the company has raised over USD$20million in funding and is now expanding its presence to other major cities around the world.

ImmunoMet Therapeutics

Series B in 2017
ImmunoMet Therapeutics is a development-stage biopharmaceutical company focused on the development and commercialization of novel oncology products that are aimed to improve the quality of life of cancer patients. With more than 6 years of experience in the field of cancer metabolism and immunometabolism, ImmunoMet has developed a comprehensive pipeline of metabolic regulators preferentially targeting the cellular metabolism of drug-resistant cancer subpopulations and immuno-suppressors of anti-cancer effector T cells.

InnoSpark

Series B in 2015
InnoSpark: Where the best innovations begin! We are a group of innovative and passionate people with a high level of expertise. Our goal is to develop and publish awesome games for global users.

The News Funnel

Angel Round in 2014
A free real estate news aggregation & PR tool website for the busy professional. Stay up-to-date on RE news that is customized to your unique interests.

ChannelBreeze

Venture Round in 2013
ChannelBreeze (채널브리즈) is a Korean company that provides social commerce services through an online platform including social network services. ChannelBreeze also provides search engine-based web services for real estate.

ZigBang

Seed Round in 2011
ZigBang is a real estate marketplace that offers an apartment hunting app. Users on Zig Bang can search for rental properties by the number of rooms, occupants, and price. Across both mobile and web versions, the startup reports 6 million users (though those aren’t all necessarily active and there might be some overlap).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.